| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Enzo Biochem Inc (NYSE: ENZ)
ENZ Technical Analysis
5
| As on 9th Jun 2023 ENZ SHARE Price closed @ 2.18 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.63 & Strong Sell for SHORT-TERM with Stoploss of 3.26 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ENZSHARE Price
| Open | 2.19 | Change | Price | % |
| High | 2.21 | 1 Day | -0.02 | -0.91 |
| Low | 2.17 | 1 Week | -0.02 | -0.91 |
| Close | 2.18 | 1 Month | -0.33 | -13.15 |
| Volume | 66900 | 1 Year | -1.00 | -31.45 |
| 52 Week High 3.47 | 52 Week Low 1.00 | ||||
NYSE USA Most Active Stocks
| DDR | 15.44 | -4.46% |
| NIO | 7.73 | -0.77% |
| TWTR | 53.70 | 0.66% |
| CVNA | 19.07 | -21.30% |
| BACA-U | 302.00 | 0.67% |
| PLTR | 15.02 | -1.12% |
| F | 13.74 | 1.18% |
| CS | 0.89 | 1.14% |
| RPAI | 13.15 | -3.17% |
| AUY | 5.85 | -0.68% |
NYSE USA Top Gainers Stocks
NYSE USA Top Losers Stocks
| ENZ Daily Charts |
ENZ Intraday Charts |
Whats New @ Bazaartrend |
ENZ Free Analysis |
|
|
ENZ Important Levels Intraday
| RESISTANCE | 2.26 |
| RESISTANCE | 2.23 |
| RESISTANCE | 2.22 |
| RESISTANCE | 2.20 |
| SUPPORT | 2.16 |
| SUPPORT | 2.14 |
| SUPPORT | 2.13 |
| SUPPORT | 2.10 |
ENZ Forecast April 2024
| 4th UP Forecast | 3.16 |
| 3rd UP Forecast | 2.85 |
| 2nd UP Forecast | 2.65 |
| 1st UP Forecast | 2.46 |
| 1st DOWN Forecast | 1.9 |
| 2nd DOWN Forecast | 1.71 |
| 3rd DOWN Forecast | 1.51 |
| 4th DOWN Forecast | 1.2 |
ENZ Weekly Forecast
| 4th UP Forecast | 2.68 |
| 3rd UP Forecast | 2.52 |
| 2nd UP Forecast | 2.42 |
| 1st UP Forecast | 2.32 |
| 1st DOWN Forecast | 2.04 |
| 2nd DOWN Forecast | 1.94 |
| 3rd DOWN Forecast | 1.84 |
| 4th DOWN Forecast | 1.68 |
ENZ Forecast2024
| 4th UP Forecast | 7.02 |
| 3rd UP Forecast | 5.47 |
| 2nd UP Forecast | 4.51 |
| 1st UP Forecast | 3.55 |
| 1st DOWN Forecast | 0.81 |
| 2nd DOWN Forecast | -0.15 |
| 3rd DOWN Forecast | -1.11 |
| 4th DOWN Forecast | -2.66 |
Enzo Biochem Inc ( NYSE USA Symbol : ENZ )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ENZ Business Profile
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products segment develops, manufactures, and markets products and tools to clinical research, drug development, and bioscience research customers. It offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. This segment also provides its products to scientific experts in the fields of cancer, cardiovascular disease, neurological disorders, diabetes and obesity, endocrine disorders, infectious and autoimmune disease, hepatotoxicity, and renal injury. The Clinical Laboratory Services segment provides molecular and other clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, and search for an otherwise undiagnosed condition. It operates a full-service clinical laboratory in Farmingdale, New York; a network of 30 patient service centers in New York and New Jersey; and a free-standing ?STAT' or rapid response laboratories in New York City and Connecticut, as well as a full-service phlebotomy center and an in-house logistics department. The Therapeutics segment develops novel approaches in the areas of gastrointestinal, infectious, ophthalmic, and metabolic diseases. It markets its products and services through its direct sales force and a network of distributors in the United States and internationally. The company was founded in 1976 and is headquartered in New York, New York. Address: 527 Madison Avenue, New York, NY, United States, 10022
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service